Clinical Trials for TKI258
1 Open Trial
| Trial Type | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic | VICCGYN1174 09/26/2012 | A Phase II, Open-Label, Single-Arm, Non-Randomized, Multi-Center Study to Evaluate the Efficacy of Oral TKI258 as Second-Line Therapy in Patients with Either FGFR2 Mutated or Wild-Type Advanced and/or Metastatic Endometrial Cancer |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
